- Home
- LENZ vs OPRX Comparison
LENZ vs OPRX Comparison
Compare LENZ & OPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LENZ | OPRX |
|---|---|---|
| Founded | 2019 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 142.0M | 137.3M |
| IPO Year | 2021 | 2008 |
Fundamental Metrics
Financial Performance| Metric | LENZ | OPRX |
|---|---|---|
| Price | $3.79 | $8.39 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 6 |
| Target Price | ★ $24.00 | $12.60 |
| AVG Volume (30 Days) | ★ 666.8K | 128.5K |
| Earning Date | 11-04-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 124.55 |
| EPS | N/A | ★ N/A |
| Revenue | $19,088,000.00 | ★ $109,429,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $153.04 | $10.43 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 18.78 |
| 52 Week Low | $3.60 | $4.54 |
| 52 Week High | $49.85 | $22.25 |
Technical Indicators
Market Signals| Indicator | LENZ | OPRX |
|---|---|---|
| Relative Strength Index (RSI) | 33.95 | 64.98 |
| Support Level | $3.60 | $7.04 |
| Resistance Level | $6.11 | $9.08 |
| Average True Range (ATR) | 0.20 | 0.38 |
| MACD | -0.02 | 0.08 |
| Stochastic Oscillator | 23.38 | 95.89 |
Price Performance
Historical ComparisonAbout LENZ LENZ Therapeutics Inc.
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products. Its products VIZZ (aceclidine ophthalmic solution) 1.44% is a once-daily eye drop developed to restore clear near vision for up to 10 hours. VIZZ is powered by aceclidine, highlighted by its differentiated mechanism of action as a predominantly pupil-selective miotic that interacts with the iris, with minimal ciliary muscle stimulation.
About OPRX OptimizeRx Corporation
OptimizeRx Corp is engaged in the healthcare market in the United States. is a digital healthcare technology company that connects over two million HCPs and millions of their patients through an intelligent technology platform embedded within a proprietary omnichannel network. OptimizeRx helps life sciences organizations engage and support their customers through its combined HCP and DTC marketing strategies.